Roth Conference Archives - Page 115 of 117

MondayMar 13, 2017 11:30 am

TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) Starts Presentation at 29th Annual Roth Conference

TRACON Pharmaceuticals (NASDAQ: TCON) is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of novel targeted therapeutics for cancer, wet age-related macular degeneration, and fibrotic diseases. Its lead product candidate is TRC105, which is in phase II clinical trials for oncology indications, including soft tissue sarcoma, renal cell carcinoma, glioblastoma, and hepatocellular carcinoma. The company’s other product candidates comprise TRC205, an endoglin antibody that is in preclinical stage for the treatment of fibrotic diseases; and TRC102, a small molecule, which is in clinical development for the treatment of lung cancer and glioblastoma. For more information, visit the…

MondayMar 13, 2017 11:30 am

Lipocine, Inc. (NASDAQ: LPCN) Starts Presentation at 29th Annual ROTH Conference

Lipocine (NASDAQ: LPCN) is a specialty pharmaceutical company that develops pharmaceutical products using its oral drug delivery technology in the areas of men’s and women’s health. The company offers a portfolio of proprietary product candidates designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. Its lead product candidate, LPCN 1021, an oral testosterone replacement therapy designed for twice-a-day dosing that has completed Phase 3 testing. The company’s pipeline candidates also include LPCN 1111, a next generation oral testosterone therapy product with once daily dosing that is…

MondayMar 13, 2017 11:30 am

Exact Sciences Corp. (NASDAQ: EXAS) Starts Presentation at 29th Annual ROTH Conference

Exact Sciences (NASDAQ: EXAS) is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. Exact Sciences’ Cologuard a noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy-to-use screening test they can do in the privacy of their own home. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. For more information, visit the company’s website at www.exactsciences.com. About NetworkNewsWire…

MondayMar 13, 2017 11:30 am

Crown Crafts, Inc. (NASDAQ: CRWS) Starts Presentation at 29th Annual ROTH Conference

Crown Crafts (NASDAQ: CRWS) designs, markets and distributes infant, toddler and juvenile consumer products. Its product line includes crib and toddler bedding, bathing accessories, reusable and disposable bibs, and disposable placemats, floor mats, toilet seat covers and changing mats. The company’s operating subsidiaries consist of Crown Crafts Infant Products, Inc. in California and Hamco, Inc. in Louisiana. Crown Crafts is among America’s largest producers of infant bedding, toddler bedding and bibs. The company’s products include licensed and branded collections, as well as exclusive private label programs for certain of its customers. For more information, visit the company’s website at www.crowncrafts.com. About NetworkNewsWire NetworkNewsWire…

MondayMar 13, 2017 11:30 am

IZEA, Inc. (NASDAQ: IZEA) Starts Presentation at 29th Annual ROTH Conference

IZEA (NASDAQ: IZEA) operates IZEAx, a technology platform that connects marketers with influential content creators. IZEAx automates influencer marketing and custom content development, allowing brands and agencies to scale their marketing programs. The company’s creators range from leading bloggers and social media personalities, to A-list celebrities and professional journalists. Creators are compensated for developing and distributing text, videos, photos and status updates through social media. Marketers receive influential content and engaging, shareable stories that drive awareness. For more information, visit the company’s website at www.izea.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

MondayMar 13, 2017 11:00 am

Web.com Group, Inc. (NASDAQ: WEB) Starts Presentation at 29th Annual Roth Conference

Web.com Group (NASDAQ: WEB) provides a range of Internet services to small businesses in North America, South America and the United Kingdom. The company’s services and products enable small businesses to establish, maintain, promote and optimize their online presence. It provides domain name registration, such as .com and .net domains, as well as a suite of domain name services. The company also offers Do-It-For-Me Web solutions, including custom websites with built in marketing, analytics, and hosting facilities; Ignite that enables Websites to be promoted in various directories; Facebook Boost by Web.com, which designs or updates the business profile page on…

MondayMar 13, 2017 11:00 am

Contango Oil & Gas Co. (NYSE: MCF) Starts Presentation at 29th Annual ROTH Conference

Contango Oil & Gas (NYSE: MCF) is a Houston, Texas based independent oil and natural gas company. The company acquires, explores, develops, exploits, and produces crude oil and natural gas properties in the offshore shallow waters of the Gulf of Mexico, and in the onshore Texas Gulf Coast and Rocky Mountain regions in the United States. For more information, visit the company’s website www.contango.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and…

MondayMar 13, 2017 11:00 am

Daqo New Energy Corp. (NYSE: DQ) Starts Presentation at 29th Annual ROTH Conference

Daqo New Energy (NYSE: DQ) is a manufacturer of high-purity polysilicon for the global solar PV industry. Founded in 2008, the low cost producer of high-purity polysilicon and solar wafers primarily sells its products to solar cell and solar module manufacturers. Daqo New Energy has built a manufacturing facility that is technically advanced and highly efficient with a nameplate capacity of 12,150 metric tons in Xinjiang, China. The company also operates a solar wafer manufacturing facility in Chongqing, China. For more information, visit the company’s website at www.dqsolar.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and…

MondayMar 13, 2017 11:00 am

Vericel Corp. (NASDAQ: VCEL) Starts Presentation at 29th Annual Roth Conference

Vericel (NASDAQ: VCEL) is a commercial-stage biopharmaceutical company that develops and sells patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two autologous cell therapy products, including Carticel, an autologous chondrocyte implant for the treatment of cartilage defects in the knee; and Epicel, a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns comprising greater than or equal to 30 percent of total body surface area in the United States. Vericel is also developing MACI, a third-generation autologous chondrocyte implant for the treatment of cartilage defects…

MondayMar 13, 2017 11:00 am

Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) Starts Presentation at 29th Annual Roth Conference

Tetraphase Pharmaceuticals (NASDAQ: TTPH) is a clinical-stage biopharmaceutical company that develops various antibiotics for the treatment of serious and life-threatening multidrug-resistant infections. Its lead product candidate includes eravacycline, an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant Gram-negative infections. The company has completed a phase 3 clinical trial of eravacycline with intravenous administration for the treatment of complicated intra-abdominal infections; and a second phase 3 clinical trial of eravacycline for the treatment of complicated urinary tract infections with intravenous-to- oral transition therapy. For more information, visit the company’s website…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Roth Conference

TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) Starts Presentation at 29th Annual Roth Conference

Lipocine, Inc. (NASDAQ: LPCN) Starts Presentation at 29th Annual ROTH Conference

Exact Sciences Corp. (NASDAQ: EXAS) Starts Presentation at 29th Annual ROTH Conference

Crown Crafts, Inc. (NASDAQ: CRWS) Starts Presentation at 29th Annual ROTH Conference

IZEA, Inc. (NASDAQ: IZEA) Starts Presentation at 29th Annual ROTH Conference

Web.com Group, Inc. (NASDAQ: WEB) Starts Presentation at 29th Annual Roth Conference

Contango Oil & Gas Co. (NYSE: MCF) Starts Presentation at 29th Annual ROTH Conference

Daqo New Energy Corp. (NYSE: DQ) Starts Presentation at 29th Annual ROTH Conference

Vericel Corp. (NASDAQ: VCEL) Starts Presentation at 29th Annual Roth Conference

Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) Starts Presentation at 29th Annual Roth Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search